GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Goodwill-to-Asset

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Goodwill-to-Asset : 0.00 (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Cannabis Bioscience International Holdings's Goodwill for the quarter that ended in Nov. 2023 was $0.00 Mil. Cannabis Bioscience International Holdings's Total Assets for the quarter that ended in Nov. 2023 was $0.10 Mil. Therefore, Cannabis Bioscience International Holdings's Goodwill to Asset Ratio for the quarter that ended in Nov. 2023 was 0.00.


Cannabis Bioscience International Holdings Goodwill-to-Asset Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Goodwill-to-Asset Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
Goodwill-to-Asset
- - - - -

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cannabis Bioscience International Holdings's Goodwill-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Goodwill-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Goodwill-to-Asset falls into.



Cannabis Bioscience International Holdings Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Cannabis Bioscience International Holdings's Goodwill to Asset Ratio for the fiscal year that ended in May. 2011 is calculated as

Goodwill to Asset (A: May. 2011 )=Goodwill/Total Assets
=0/93.043
=0.00

Cannabis Bioscience International Holdings's Goodwill to Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

Goodwill to Asset (Q: Nov. 2023 )=Goodwill/Total Assets
=0/0.102
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Cannabis Bioscience International Holdings Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines